Fig. 2From: Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohortComparisons of neoepitope concentrations for collagen synthesis markers in healthy control and participants with stable and progressive IPF, measured at baseline, 1, 3 and 6 months after baseline for collagen-type 1 (P1NP), −type 3 (PRO-C3) and -type 6 (PRO-C6). Plots represent mean and 95% CI (error bars) adjusted for age, sex, site and smoking status. Disease progression was defined as all-cause mortality or ≧10% decline in forced vital capacity at 12 months. The number of evaluable samples available for analysis at each time point are provided in the graph. P values are provided where significant (p < 0.05) differences were observed between stable and progressive disease at a particular time point. Triangles represent which groups were compared at each time point on the graph, based on colourBack to article page